Product Portfolio
Barkan-Farma's innovative therapies comprise a patented chemical entity that has been clinically tested and proved to be highly effective and safe in a variety of clinical indications listed below:
• Migraine and acute headache
• Acute hypotension induced by cardiac surgeries, cardiopulmonary bypass, carcinogenic shock, cardiac catheterization, hemodialysis, trauma, intra/post operative hypovolemic shock, septic shock, epidural and spinal anesthesia;
• Rhinorrhea and allergic rhinitis
• Menorrhagia, including excessive postpartum bleeding and pain syndrome
Based on the patented chemical entity, Barkan-Farma has developed a unique pipeline of products that includes:
• Ravimig® 50mg, 2 tablets p/box: oral formulation tablet indicated for Migraine. Prescription drug.
• Raviten® 10%, 5 vials p/box: i.v. formulation, emergency resuscitation vassopressor drug used for the treatment of acute hypotension conditions that occur during surgeries, and as a result of trauma, hemorrhage, poisoning and septic shock. Prescription drug.
• Ravirin® Spray, 0.2%: Barkan-Farma's proprietary nasal dosing spray indicated for running nose and allergic rhinitis.
• Raviset® 100mg, 6 units p/box: exclusive vaginal suppositories indicated for menorrhagia and excessive postpartum bleeding. Prescription drug.
